Abstract
Human OPN (Fig. 1) is a highly negatively charged protein of 314 amino acids (Mr 34-kD) and appears to lack complexity in secondary structure [11]. It has a number of highly conserved structural elements, including RGD (arginine-glycine-aspartate) and SVVYGLR (serine-valine-valine-tyrosine-glycine-leucine-arginine) domains for integrin binding, a calcium binding site and heparin binding domains that mediate CD44 receptor binding [7]. In addition to full length OPN (OPN-a), two other splice variants, OPN-b and OPN-c, are known to occur and likely display functional heterogeneity
. All forms of OPN are subject to extensive post-translational modifications including serine/threonine phosphorylation, glycosylation and tyrosine sulphation, which allow for a monomeric molecular weight ranging from 41 to 75 kD [14] . These modifications can be cell type specific [15] , may depend on other physiological and pathophysiological factors and likely impact both OPN structure and function [16, 17] . For example, Al-Shami et al. [18] [24] . Finally, proteolytic fragmentation of OPN by thrombin [25] or matrix metalloproteinases (MMPs) [26, 27] can generate OPN forms having potential physiological and pathological importance [11, 28] . However, much remains to be learned about the functional properties of these various forms of the OPN protein. [7, 29] . This [45, 46] and multiple myeloma [47] [53, 54] ). [55] . OPN has been found in the extracellular matrix of various cancers by immunohistochemistry [49-51, 56, 57] . However, it has been argued that at least in some instances, tumour-derived OPN may be more soluble and not incorporated into the extracellular matrix [58] . Thus, it is unclear whether it is tumour-or stromal-derived OPN (or both) that can be incorporated into the extracellular matrix and affect tumour growth and progression. [11, 14, 15, 18, 59] [80] .
have reported that dephosphorylation of highly phosphorylated OPN reduces its ability to stimulate the migration of human choriocarcinoma cells. Interestingly, however, bacterially produced OPN (which lacks eukaryotic post-translational modifications) has been shown to be functional in some experimental assays, such as adhesion and migration of MDA-MB-435 cells and 21T series mammary epithelial cells [19-23]. Additionally, transglutaminase crosslinking of OPN via two glutamine residues in the N-terminal half of the molecule can be important in its biological activity by altering adhesion and migration abilities

OPN binds to a number of cell surface receptors, including members of the integrin and CD44 families, and indirectly influences the activity of growth factor receptors such as epidermal growth factor receptor and Met
There is conflicting evidence on whether tumour-derived OPN is incorporated into the extracellular matrix. In some tissues, such as bone, OPN is an established component of the extracellular matrix and is important in cell attachment
Effect of OPN on the tumour microenvironment
Because it is a secreted protein, OPN produced by tumour cells can influence cells in the tumour microenvironment and vice versa (Fig. 2). Whether tumour-derived OPN differs, structurally or functionally, in its effects compared to stromal-derived OPN is largely unknown. Although there is evidence that different OPN isoforms and post-translational modifications (e.g. phosphorylation, sialation, proteolytic cleavage, transglutaminse crosslinking, proteolytic processing) may affect different OPN functions
OPN may also play a role in the formation of calcifications in breast cancers [81] . High levels of OPN have been detected in calcifications of both benign and malignant breast tissues [82] . Calcifications are more frequent in tumours overexpressing OPN than in OPN -tumours [83] . [92] . OPN has been shown to be up-regulated during and required for the differentiation of fibroblasts into myofibroblasts [93, 94] and this may be one mechanism by which OPN facilitates tumour progression. Increased OPN expression in fibroblasts has also been seen in cell senescence [95] , and senescent fibroblasts have also been shown to promote pre-neoplastic growth in vitro and in vivo [96] . Conversely, reduction of OPN expression in senescent fibroblasts by RNA interference has been shown to reduce their growth-promoting influence [95] . Consistent with these findings, cancer-associated fibroblasts recruited into the stroma by platelet-derived growth factor-CC elaborated by tumour cells have also been shown to overexpress OPN and promote tumour growth [97] .
The presence of OPN in the microenvironment of a metastasis may also lead to increased tumour take at a secondary site. Allan et al. [98] 
OPN in the bone microenvironment
OPN is produced by osteoblasts, osteoclasts, osteocytes and macrophages in the bone microenvironment [100] . In bone metastases, expression of OPN has been detected in both osteoclasts and metastatic tumour cells [101] . Kang et al. [102] 
